Loading...
XASXHYD
Market cap1mUSD
Dec 23, Last price  
0.01AUD
1D
-16.67%
1Q
-23.08%
Jan 2017
-98.04%
Name

Hydrix Ltd

Chart & Performance

D1W1MN
XASX:HYD chart
P/E
—
P/S
0.26
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
100.54%
Rev. gr., 5y
-5.56%
Revenues
11m
-19.20%
267,120135,007113,478169,110020,60110,77131,17515,16719,055170,27998,46430,2465,708,16214,150,35314,934,2257,445,22110,325,01813,156,57210,630,839
Net income
-10m
L+2,308.22%
-363,567-727,105-13,771,134-2,478,616-1,805,685-956,875-3,706,097-1,466,408-1,651,383-1,419,513-4,020,406-4,880,714-4,375,949-5,080,967-4,219,742-3,219,461-9,778,693-5,546,389-396,926-9,558,852
CFO
-2m
L-39.40%
-86,677-273,037-397,802-1,149,705-959,191-805,998-1,378,048-1,433,803-615,052-1,090,627-2,950,792-2,855,566-2,764,828-3,809,272-4,197,025-1,316,565-2,861,522-6,581,789-3,121,313-1,891,650
Earnings
Feb 26, 2025

Profile

Hydrix Limited provides product design, engineering, and regulatory services in Australia, Singapore, Europe, North America, and internationally. It operates through two segments: Hydrix Services and Hydrix Medical. It provides cardiovascular products, such as The GUARDIAN, a cardiac monitoring and alerting device that reduces the stresses of living; Phyzhon PHYRARI FFR-Wire enables cardiologists to combine diagnosis procedures with delivery of therapy including stents; and LUDO, a customizable plug-and-play platform that provides critical tools to start MCS pump development. The company also offers a range of services, including product development, regulatory and clinical consulting, and technology commercialization. It serves medical, consumer, industrial, utilities, defense, aerospace, and mining industries. The company was formerly known as Panorama Synergy Limited and changed its name to Hydrix Limited in November 2018. Hydrix Limited was incorporated in 1993 and is headquartered in Mulgrave, Australia
URL
https://www.hydrix.com/
IPO date
May 11, 2001
Employees
70
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
10,631
-19.20%
13,157
27.42%
10,325
38.68%
Cost of revenue
12,051
26,228
25,184
Unusual Expense (Income)
NOPBT
(1,421)
(13,072)
(14,859)
NOPBT Margin
Operating Taxes
(67)
(106)
Tax Rate
NOPAT
(1,421)
(13,004)
(14,753)
Net income
(9,559)
2,308.22%
(397)
-92.84%
(5,546)
-43.28%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,562
2,426
BB yield
-41.19%
-16.70%
Debt
Debt current
2,967
2,224
1,792
Long-term debt
6,893
4,014
3,612
Deferred revenue
Other long-term liabilities
433
357
2,697
Net debt
5,529
192
(376)
Cash flow
Cash from operating activities
(1,892)
(3,121)
(6,582)
CAPEX
(14)
(200)
(170)
Cash from investing activities
(53)
(210)
(307)
Cash from financing activities
1,707
2,543
2,182
FCF
(177)
(14,348)
(12,341)
Balance
Cash
914
1,153
1,940
Long term investments
3,416
4,894
3,839
Excess cash
3,799
5,389
5,264
Stockholders' equity
(3,355)
6,353
3,276
Invested Capital
8,038
6,053
5,738
ROIC
ROCE
EV
Common stock shares outstanding
254,219
239,245
196,311
Price
0.01
-46.15%
0.03
-64.86%
0.07
-60.00%
Market cap
3,559
-42.78%
6,220
-57.18%
14,527
-51.30%
EV
9,088
6,412
14,151
EBITDA
(477)
(11,753)
(13,701)
EV/EBITDA
Interest
699
446
448
Interest/NOPBT